HCV genotype distribution among HIV co-infected individuals in Argentina: Relationship with host and viral factors

Acta Gastroenterologica Latinoamericana

Volumn 37, Issue 2, 2007, Pages 76-83

  Quarleri, Jorge F ^a,e   Bolcic, Federico M ^a   Bouzas, María B ^b   Laufer, Natalia ^d   Carrillo, Manuel Gómez ^a   Mammana, Lilia ^b   Kaufman, S ^c   Perez H ^d   Cahn, P ^d   Salomon, H ^a  

^a CONICET ^*  (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

^c Centro Medico Huesped   (Argentina)

^d HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ARGENTINA; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; STATISTICS; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ARGENTINA; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; VIRAL LOAD;

EID: 34447262343     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Simmonds P, Variability of hepatitis C virus, Hepatology 1995;21,570-583.
2. Roffi L, Colloredo G, Brugnetti B, Bellati G, Ricci A, Scalori A, Antonelli G, Panizzuti F, Pozzi M, Pioltelli P, Mancia G. HCV genotypes and breakthrough in patients treated with recombinant alpha interferon, Am. J. Gastroenterol. 1998;93,1602-1603.
3. Sherman K.E, S.D. Rouster, R.T. Chung, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials group, Clin Infect Dis. 2002;34,831-837.
4. Tedaldi E.M, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, Jenny-Avital ER, McGowan JP, Perez G. Terry Beirn Community Programs for Clinical Research on AIDS. Prevalence and characteristics of hepatitis C virus co-infection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on Aids, Clin Infect Dis. 2003;36,1313-1317.
5. Fainboim H, Gonzalez J, Fassio E, Martinez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, Gancedo E, Castro R, Brajterman L, Laplume H. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat. 1999;6,53-57.
6. Pando M, Biglione MM, Toscano MF, Rey JA, Russell KL, Negrete M, Gianni S, Martinez-Peralta L, Salomon H, Sosa-Estani S, Montano SM, Olson JG, Sanchez JL, Carr JK, Avila MM. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina. Am J Trop Med Hyg. 2004;71,153-159.
7. Weissenbacher M, Rossi D, Radulich G, Sosa-Estani S, Vila M, Vivas E, Avila MM, Cuchi P, Rey J, Peralta LM. High seroprevalence of blood borne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis. 2003;37,S348-S352.
8. Monga H.K, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, Yoffe B. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection, Clin Infect Dis. 2001;33,240-247.
9. De Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P. The influence of human immunodeficiency virus co-infection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study, Hepatology 2001;34,1193-1199.
10. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus co-infection: the Swiss HIV Cohort Study, Lancet. 2000;356,1800-1805.
11. Daar E.S, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA; Hemophilia Growth and Development Study. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs, J Infect Dis. 2001;183,589-595.
12. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep; 2003;52,13-15.
13. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS. 1995;9(10):1131-1136.
14. Quarleri J.F, Robertson BH, Mathet VL, Feld M, Espinola L, Requeijo MP, Mando O, Carballal G, Oubina JR. Genomic and phylogenetic analysis of hepatitis C virus isolates from Argentine patients: a six-year retrospective study. J Clin Microbiol. 2000;38,4560-4568.
15. Quarleri J.F, Bussy MV, Mathet VL, Ruiz V, Iacono R, Lu L, Robertson BH, Oubina JR. In vitro detection of dissimilar amounts of hepatitis C virus (HCV) subtype-specific RNA genomes in mixes prepared from sera of persons infected with a single HCV genotype. J Clin Microbiol. 2003;41,2727-2733.
16. Davidson F, P Simmonds, JC Ferguson, LM Jarvis, BC Dow, EA Follett, CR Seed, T Krusius, C Lin and GA Medgyesi. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol. 1995;76,1197-1204.
17. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002;122:1554-1568.
18. Hollander M. and Wolfe D.A., 1999 In: M. Hollander and D.A. Wolfe, Editors, Nonparametric statistical methods (2nd ed.), Wiley, New York (1999).
19. Theodorsson-Norheim E. Kruskal-Wallis test: BASIC computer program to perform nonparametric one-way analysis of variance and multiple comparisons on ranks of several independent samples. Comput Methods Programs Biomed.1986;23,57-62.
20. Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr. 2001;26(4):340-344.
21. Lapane KL, Jakiche AF, Sugano D, Weng CS, Carey WD. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Am J Gastroenterol. 1998;93,591-596.
22. De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group. Co-infection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naïve HIV-infected subjects, Arch Intern Med. 2002,162,2125-2132.
23. Nuñez M, Rios P, Martin-Carbonero L, Perez-Olmeda M, Gonzalez-Lahoz J, Soriano V. Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2002;30,65-68.
24. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M, Gerolami V, Halfon P, Buisson Y, Fouqueray B, Loiseau P, Lamoril J, Lefrere JJ, Marcellin P. 1999. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. J. Viral Hepat. 1999;6,435-443.
25. Caudai C, Pianese M, Zacchini F, Toti M, Zazzi M, Valensin PE. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype. J Clin Virol. 2005;32,151-155.
26. Findor J, Sorda JA, Daruich J, Bruch Igartua E, Manero E, Avagnina A, Benbassat D, Rey J, Nakatsuno M. Distribution of the genotypes of hepatitis C virus in intravenous drug addicts in Argentina. Medicina 1999;59,49-54.
27. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995,171, 1607-1610.
28. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users, J. Viral Hepat. 2002;9,62-70.
29. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use, J. Med. Virol. 2001;65,517-524.
30. Picchio G.R, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Perez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. J Med Virol. 1997;52, 219-225.
31. Siri P, Inchaurraga S. 'First steps': using rapid assessment and response methods to develop research, intervention and advocacy capacity for addressing drug use in Rosario City, Argentina. Int J Drug Policy. 2000;11,125-132.
32. Kontorinis N, Agarwal K, Dieterich DT. Treatment of hepatitis C virus in HIV patients: a review. AIDS. 2005;19, 166-173.
33. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat. 2005;12,322-324.
34. Roque-Afonso AM, Ducoulombier D, Di Liberto G, Kara R, Gigou M, Dussaix E, Samuel D, Feray C. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol. 2005;79(10):6349-6357.
35. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL Jr, Wood BL, Perkins JD, Gretch DR. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology. 2006;130(4):1107-1116.
36. Yoo T.W, Donfield S, Lail A, Lynn HS, Daar ES; Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis. 2005;191,4-10.